Further exploration revealed that the downregulation of HMGB1 expression effectively inhibited the NF-κB/p65 and its binding activity to DNA, thereby reducing the expression of vascular endothelial growth factor C (VEGF-C) and impeding tumor angiogenesis. This evidence concerns the gene VEGFC and neoplasm.